These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol. Siegmund W, Ludwig K, Giessmann T, Dazert P, Schroeder E, Sperker B, Warzok R, Kroemer HK, Cascorbi I. Clin Pharmacol Ther; 2002 Nov; 72(5):572-83. PubMed ID: 12426521 [Abstract] [Full Text] [Related]
12. Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms. Hemauer SJ, Nanovskaya TN, Abdel-Rahman SZ, Patrikeeva SL, Hankins GD, Ahmed MS. Biochem Pharmacol; 2010 Mar 15; 79(6):921-5. PubMed ID: 19896927 [Abstract] [Full Text] [Related]
13. C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation. Goto M, Masuda S, Saito H, Uemoto S, Kiuchi T, Tanaka K, Inui K. Pharmacogenetics; 2002 Aug 15; 12(6):451-7. PubMed ID: 12172213 [Abstract] [Full Text] [Related]
18. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells. Stein U, Lage H, Jordan A, Walther W, Bates SE, Litman T, Hohenberger P, Dietel M. Int J Cancer; 2002 Feb 20; 97(6):751-60. PubMed ID: 11857350 [Abstract] [Full Text] [Related]
19. A T3587G germ-line mutation of the MDR1 gene encodes a nonfunctional P-glycoprotein. Mutoh K, Mitsuhashi J, Kimura Y, Tsukahara S, Ishikawa E, Sai K, Ozawa S, Sawada J, Ueda K, Katayama K, Sugimoto Y. Mol Cancer Ther; 2006 Apr 20; 5(4):877-84. PubMed ID: 16648557 [Abstract] [Full Text] [Related]